Molecular Medicine | Cell Point Web Map

Molecular Medicine Ph.D. Program is a unique collaborative graduate training opportunity that integrates medical knowledge into graduate training. The goal of this program is to produce scientists trained in translational research - basic or applied research relevant to human health and disease that can lead to new understanding of disease, clinical and diagnostic tools, medications, and therapies.

This program is funded by the Howard Hughes Medical Institute "Med Into Grad" initiative and is consistent with National Institutes of Health Roadmap directives.

Students train rigorously to apply basic science discoveries to human health and to the causes and treatments of human disease. The mastery of competencies necessary to translate scientific observations from the research bench to clinical care is the focus of this Ph.D. program. Graduates will be well prepared to collaborate with physicians and for the challenge of using molecular and cellular biology to advance human health.

  • bout Us
  • Managament
  • Scientific Advisory Board
  • Scientific Advisory Board
  • Technology
  • Pipeline
  • R & D
  • Patents
  • Clinical Trials
  • Partners
  • Investor Info
  • News
  • Articles
  • Contact Us
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and  Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and  Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and  Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Agents & Pipeline
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • News 2|22|05
  • Confirmation
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Quarterly Reports
  • Managment
  • Video
  • Cell>Point featured on CNBC — 9|7|06
  • Video
  • News 6|3|05
  • css/sample.html
  • Video
  • 99mTc-EC-Annexin V
  • Clinical Trials
  • bottom
  • Pipeline
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Articles
  • test/coldfusion/test.html
  • Cell>Point, L.L.C. Executes Exclusive Worldwide Patent and Technology License Agreement for ethylenedicysteine — 7|1|01
  • News 4|21|05
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • 99mTc-EC-Annexin V
  • 99mTc-EC-Cox-2
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • test/miva/test.html
  • OLD/includes/leftside.htm
  • News 9|7|06
  • test/ssi/test.shtml
  • Quarterly Reports
  • News 6|1|06
  • EC Technology featured in Basel, Switzerland — 4|21|05
  • News 11|8|05
  • News 10|1|02
  • News 4|20|05
  • Cell>Point Receives Approval of its Investigations New Drug Application for 99mTc-EC-Deoxyglucose — 6|1|02
  • 99mTc-EC-MN
  • 99mTc-EC-DG
  • test/cgi/test.html
  • News 2|22|05
  • Articles
  • Contact Us
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Radiotherapy Agents
  • Cell>Point to present at 30th Annual Deutsche Bank Health Care Conference — 4|20|05
  • diabetes molecular imaging agents: Cell Point Web
  • Articles
  • News 6|3|05
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • includes/drop-down-menu.html
  • Corporate fact sheet
  • Quarterly Reports
  • News
  • Flash MP3 Player
  • News 7|1|03
  • stroke imaging agents: Cell Point Web
  • Cell>Point featured in Aunt Minnie — 5|20|05
  • Board
  • Pipeline
  • Downstream Products
  • Privacy Policy
  • test/php/test.html
  • News 9|7|06
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Agents & Pipeline
  • Contact Us
  • Cell>Point completes clinical pilot study on <sup>99m</sup>Tc-EC-Annexin V — 4|1|04
  • includes/leftside.htm
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • About us
  • 68Ga-EC-Guanosin and 68Ga-EC-MN
  • 68Ga-EC-Guanosin and 68Ga-EC-MN
  • News 11|8|05
  • 99mTc-EC-Guanosin
  • News 4|20|05
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Cell>Point acquires N4 Technology License — 3|1|05
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Cell>Point L.L.C. Completes Exclusive License Negotiations for Second Technology Platform In Situ Hydrogel — 7|1|03
  • Board
  • Cell Point Web: cellectar, oncology imaging agents, cardiology imaging agents, stroke imaging agents, diabetes molecular imaging agents, intra-nuclear metallic therapeutics
  • Video
  • 99mTc-EC-DG
  • News 5|20|05
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Heading 1
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • test/apacheasp/test.asp
  • News 9|12|06
  • News 9|29|03
  • oncology imaging agents: Cell Point Web
  • 99mTc-EC-LHRH
  • News 7|1|03
  • 99mTc-EC-LHRH
  • intra-nuclear metallic therapeutics: Cell Point Web
  • News
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • Cellectar is a radiopharmaceutical company that designs and develops products to detect, treat and monitor a wide variety of human cancers
  • Cell>Point acquires Oligosaccharide Conjugate License — 6|3|05
  • Video
  • Cell>Point L.L.C. Preparing to Conduct Studies — 10|1|02
  • Clinical Trials
  • Site Map
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • New Page 1
  • Quarterly Reports
  • News 7|1|01
  • Patents
  • News 6|1|02
  • R & D
  • EC Mechanism of Action
  • News 4|1|04
  • News 3|1|05
  • News 5|20|05
  • Quarterly Reports
  • EC Mechanism of Action
  • News 9|12|06
  • test/python/test.html
  • News 9|29|03
  • Radiotherapy Agents
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • cardiology imaging agents: Cell Point Web
  • 99mTc-EC-Guanosin
  • EC Mechanism
  • test/fcgi/test.html
  • Clinical Trials
  • Clinical Trials
  • Managment
  • test/ssi/test.html
  • Video
  • Sexy Drop Down Menu with CSS & jQuery - Tutorial by Soh Tanaka - www.SohTanaka.com
  • 99mTc-EC-Cox-2
  • R & D
  • OLD/css/sample.html
  • Cell Point Web: cellectar, oncology imaging agents, cardiology imaging agents, stroke imaging agents, diabetes molecular imaging agents, intra-nuclear metallic therapeutics
  • Confirmation
  • Video
  • Royal Philips Electronics collaborates with Cell>Point — 9|29|03
  • test/apacheasp/test.html
  • EC Mechanism of Action
  • bottom
  • Downstream Products
  • Clinical Trials
  • Cell>Point featured on CNBC — 9|7|06
  • News 4|21|05
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • 99mTc-EC-MN
  • test/coldfusion/test.cfm
  • News 7|1|01
  • Cell>Point to Present at Rice Forum — 2|22|05
  • About us
  • Cell>Point named Biotech Rising Star of the Year — 11|8|05
  • News 6|1|02
  • Quarterly Reports
  • News 4|1|04
  • News 3|1|05
  • Corporate fact sheet
  • News 6|1|06
  • test/perl/test.html
  • Cell>Point expands clinical trial for Imaging Myocardial Viability — 6|1|06
  • News
  • CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point
  • News 10|1|02
  •  

    Molecular Medicine | Cell Point Web Map

    Address: 7120 E. Orchard Rd., Suite 350 Centennial, Colorado 80111
    Phone: 303-689-9693
    E-mail: info@cellpointweb.com